000 01238 a2200325 4500
005 20250513203021.0
264 0 _c20000302
008 200003s 0 0 eng d
022 _a1359-6535
040 _aNLM
_beng
_cNLM
100 1 _aRevicki, D A
245 0 0 _aQuality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3.
_h[electronic resource]
260 _bAntiviral therapy
_c1999
300 _a35-44 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aQuality of Life
650 0 4 _aSaquinavir
_xadministration & dosage
650 0 4 _aZalcitabine
_xadministration & dosage
700 1 _aSwartz, C
700 1 _aWu, A W
700 1 _aHaubrich, R
700 1 _aCollier, A C
773 0 _tAntiviral therapy
_gvol. 4
_gno. 1
_gp. 35-44
999 _c10636412
_d10636412